While mPEG/pmIL-12 polymersomes did not affect CD3+CD4+ cells in the tumor, there was a 2-fold increase of CD3+CD8+ cells and significant increases of CD3−NK1.1+ and CD3+NK1.1+ cells in the tumor. Here, SPRR2A is linked to neoplasm.